(-)-demecolcine decreases expression ISO RGD:1312852 6480464 Demecolcine results in decreased expression of ARHGAP18 mRNA CTD PMID:23649840 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1312852 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ARHGAP18 mRNA CTD PMID:22079256 1,2-dimethylhydrazine decreases expression ISO RGD:1312853 6480464 1, 2-Dimethylhydrazine results in decreased expression of ARHGAP18 mRNA CTD PMID:22206623 17alpha-ethynylestradiol increases expression ISO RGD:1312853 6480464 Ethinyl Estradiol results in increased expression of ARHGAP18 mRNA CTD PMID:17942748 17alpha-ethynylestradiol affects expression ISO RGD:1312853 6480464 Ethinyl Estradiol affects the expression of ARHGAP18 mRNA CTD PMID:17555576 17alpha-ethynylestradiol multiple interactions ISO RGD:1312853 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of ARHGAP18 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:1312852 6480464 [Estradiol binds to ESR2 protein] which results in increased expression of ARHGAP18 mRNA CTD PMID:20404318 17beta-estradiol decreases expression ISO RGD:1312852 6480464 Estradiol results in decreased expression of ARHGAP18 mRNA CTD PMID:31614463 2,3',4,4',5-Pentachlorobiphenyl decreases expression ISO RGD:1312853 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1312852 6480464 Tetrachlorodibenzodioxin results in decreased expression of ARHGAP18 mRNA CTD PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of ARHGAP18 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1312853 6480464 Tetrachlorodibenzodioxin results in decreased expression of ARHGAP18 mRNA CTD PMID:19933214 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1312853 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of ARHGAP18 mRNA CTD PMID:17942748 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of ARHGAP18 mRNA CTD PMID:21346803 4-hydroxyphenyl retinamide increases expression ISO RGD:1312853 6480464 Fenretinide results in increased expression of ARHGAP18 mRNA CTD PMID:28973697 all-trans-retinoic acid decreases expression ISO RGD:1312852 6480464 Tretinoin results in decreased expression of ARHGAP18 mRNA CTD PMID:21934132 all-trans-retinoic acid increases expression ISO RGD:1312852 6480464 Tretinoin results in increased expression of ARHGAP18 mRNA CTD PMID:33167477 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of ARHGAP18 mRNA CTD PMID:30779732 antirheumatic drug decreases expression ISO RGD:1312852 6480464 Antirheumatic Agents results in decreased expression of ARHGAP18 mRNA CTD PMID:24449571 arsenous acid decreases expression ISO RGD:1312852 6480464 Arsenic Trioxide results in decreased expression of ARHGAP18 mRNA CTD PMID:27829220 benzene multiple interactions EXP 6480464 [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of ARHGAP18 mRNA CTD PMID:17905399 benzo[a]pyrene decreases expression ISO RGD:1312852 6480464 Benzo(a)pyrene results in decreased expression of ARHGAP18 mRNA CTD PMID:20064835 more ... benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1312852 6480464 7 more ... CTD PMID:19150397 benzo[a]pyrene diol epoxide I affects expression ISO RGD:1312852 6480464 7 more ... CTD PMID:20382639 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1312852 6480464 Diethylhexyl Phthalate results in increased expression of ARHGAP18 mRNA, Diethylhexyl Phthalate results in increased expression of ARHGAP18 protein CTD PMID:31163220 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ARHGAP18 mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:1312853 6480464 bisphenol A results in increased expression of ARHGAP18 mRNA CTD PMID:34585602 bisphenol A affects methylation ISO RGD:1312852 6480464 bisphenol A affects the methylation of ARHGAP18 gene CTD PMID:31601247 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ARHGAP18 mRNA CTD PMID:34947998 bisphenol A multiple interactions ISO RGD:1312852 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of ARHGAP18 gene CTD PMID:31601247 bisphenol A affects expression ISO RGD:1312852 6480464 bisphenol A affects the expression of ARHGAP18 mRNA CTD PMID:30903817 bisphenol A decreases expression ISO RGD:1312852 6480464 bisphenol A results in decreased expression of ARHGAP18 mRNA CTD PMID:29275510 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of ARHGAP18 gene CTD PMID:28505145 cadmium dichloride increases expression ISO RGD:1312852 6480464 Cadmium Chloride results in increased expression of ARHGAP18 mRNA CTD PMID:26472689 carbamazepine affects expression ISO RGD:1312852 6480464 Carbamazepine affects the expression of ARHGAP18 mRNA CTD PMID:25979313 carbon nanotube decreases expression ISO RGD:1312853 6480464 Nanotubes more ... CTD PMID:25620056 chlordecone increases expression ISO RGD:1312853 6480464 Chlordecone results in increased expression of ARHGAP18 mRNA CTD PMID:33711761 chromium(6+) affects expression ISO RGD:1312853 6480464 chromium hexavalent ion affects the expression of ARHGAP18 mRNA CTD PMID:28472532 cobalt dichloride decreases expression ISO RGD:1312852 6480464 cobaltous chloride results in decreased expression of ARHGAP18 mRNA CTD PMID:19320972 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of ARHGAP18 mRNA CTD PMID:24386269 copper atom decreases expression EXP 6480464 Copper results in decreased expression of ARHGAP18 mRNA CTD PMID:30556269 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of ARHGAP18 mRNA CTD PMID:30556269 copper(II) sulfate decreases expression ISO RGD:1312852 6480464 Copper Sulfate results in decreased expression of ARHGAP18 mRNA CTD PMID:19549813 cyclosporin A decreases expression ISO RGD:1312852 6480464 Cyclosporine results in decreased expression of ARHGAP18 mRNA CTD PMID:25562108 diarsenic trioxide decreases expression ISO RGD:1312852 6480464 Arsenic Trioxide results in decreased expression of ARHGAP18 mRNA CTD PMID:27829220 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of ARHGAP18 mRNA CTD PMID:21266533 dibutyl phthalate increases expression ISO RGD:1312853 6480464 Dibutyl Phthalate results in increased expression of ARHGAP18 mRNA CTD PMID:17361019 , PMID:21266533 dicrotophos decreases expression ISO RGD:1312852 6480464 dicrotophos results in decreased expression of ARHGAP18 mRNA CTD PMID:28302478 dorsomorphin multiple interactions ISO RGD:1312852 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1312852 6480464 Doxorubicin results in decreased expression of ARHGAP18 mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of ARHGAP18 mRNA CTD PMID:29391264 ethanol affects expression ISO RGD:1312853 6480464 Ethanol affects the expression of ARHGAP18 mRNA CTD PMID:30319688 ethyl methanesulfonate decreases expression ISO RGD:1312852 6480464 Ethyl Methanesulfonate results in decreased expression of ARHGAP18 mRNA CTD PMID:23649840 fenamidone increases expression ISO RGD:1312853 6480464 fenamidone results in increased expression of ARHGAP18 mRNA CTD PMID:27029645 formaldehyde decreases expression ISO RGD:1312852 6480464 Formaldehyde results in decreased expression of ARHGAP18 mRNA CTD PMID:23649840 fulvestrant multiple interactions ISO RGD:1312852 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of ARHGAP18 gene CTD PMID:31601247 furan increases expression EXP 6480464 furan results in increased expression of ARHGAP18 mRNA CTD PMID:25539665 genistein increases methylation EXP 6480464 Genistein results in increased methylation of ARHGAP18 gene CTD PMID:28505145 genistein decreases methylation EXP 6480464 Genistein results in decreased methylation of ARHGAP18 gene CTD PMID:28505145 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of ARHGAP18 mRNA CTD PMID:22061828 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of ARHGAP18 mRNA CTD PMID:24136188 hydrogen peroxide increases expression ISO RGD:1312852 6480464 Hydrogen Peroxide results in increased expression of ARHGAP18 mRNA CTD PMID:18951874 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of ARHGAP18 mRNA CTD PMID:21396975 isoprenaline decreases expression ISO RGD:1312853 6480464 Isoproterenol results in decreased expression of ARHGAP18 mRNA CTD PMID:20003209 ivermectin decreases expression ISO RGD:1312852 6480464 Ivermectin results in decreased expression of ARHGAP18 protein CTD PMID:32959892 melphalan decreases expression ISO RGD:1312852 6480464 Melphalan results in decreased expression of ARHGAP18 mRNA CTD PMID:22363485 mercury dibromide increases expression ISO RGD:1312852 6480464 mercuric bromide results in increased expression of ARHGAP18 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1312852 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP18 mRNA CTD PMID:27188386 methyl methanesulfonate decreases expression ISO RGD:1312852 6480464 Methyl Methanesulfonate results in decreased expression of ARHGAP18 mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO RGD:1312852 6480464 methylmercuric chloride results in decreased expression of ARHGAP18 mRNA CTD PMID:28001369 methylmercury(1+) multiple interactions EXP 6480464 [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of ARHGAP18 mRNA CTD PMID:17905399 nickel sulfate increases expression ISO RGD:1312852 6480464 nickel sulfate results in increased expression of ARHGAP18 mRNA CTD PMID:22714537 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of ARHGAP18 mRNA CTD PMID:33484710 p-toluidine increases expression EXP 6480464 4-toluidine results in increased expression of ARHGAP18 mRNA CTD PMID:27638505 panobinostat increases expression ISO RGD:1312852 6480464 panobinostat results in increased expression of ARHGAP18 mRNA CTD PMID:26272509 panobinostat multiple interactions ISO RGD:1312852 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP18 mRNA CTD PMID:27188386 paracetamol decreases expression ISO RGD:1312852 6480464 Acetaminophen results in decreased expression of ARHGAP18 mRNA CTD PMID:21420995 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of ARHGAP18 mRNA CTD PMID:33387578 perfluorooctanoic acid decreases expression ISO RGD:1312852 6480464 perfluorooctanoic acid results in decreased expression of ARHGAP18 protein CTD PMID:26879310 phenobarbital affects expression ISO RGD:1312853 6480464 Phenobarbital affects the expression of ARHGAP18 mRNA CTD PMID:23091169 phenylmercury acetate increases expression ISO RGD:1312852 6480464 Phenylmercuric Acetate results in increased expression of ARHGAP18 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1312852 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP18 mRNA CTD PMID:27188386 pirinixic acid multiple interactions ISO RGD:1312852 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ARHGAP18 mRNA CTD PMID:19710929 potassium chromate decreases expression ISO RGD:1312852 6480464 potassium chromate(VI) results in decreased expression of ARHGAP18 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:1312852 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ARHGAP18 mRNA CTD PMID:22079256 progesterone decreases expression ISO RGD:1312852 6480464 Progesterone results in decreased expression of ARHGAP18 mRNA CTD PMID:20864642 quercetin decreases expression ISO RGD:1312852 6480464 Quercetin results in decreased expression of ARHGAP18 mRNA CTD PMID:21632981 SB 431542 multiple interactions ISO RGD:1312852 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:1312852 6480464 Silicon Dioxide analog results in decreased expression of ARHGAP18 mRNA CTD PMID:25895662 sodium arsenite decreases expression ISO RGD:1312852 6480464 sodium arsenite results in decreased expression of ARHGAP18 mRNA CTD PMID:20371982 sodium arsenite increases expression ISO RGD:1312852 6480464 sodium arsenite results in increased expression of ARHGAP18 mRNA CTD PMID:22714537 succimer multiple interactions ISO RGD:1312853 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ARHGAP18 mRNA CTD PMID:21641980 sunitinib decreases expression ISO RGD:1312852 6480464 Sunitinib results in decreased expression of ARHGAP18 mRNA CTD PMID:31533062 T-2 toxin decreases expression EXP 6480464 T-2 Toxin results in decreased expression of ARHGAP18 mRNA CTD PMID:26141394 tamoxifen affects expression ISO RGD:1312853 6480464 Tamoxifen affects the expression of ARHGAP18 mRNA CTD PMID:17555576 testosterone decreases expression ISO RGD:1312852 6480464 Testosterone results in decreased expression of ARHGAP18 mRNA CTD PMID:33359661 tetrachloromethane increases expression ISO RGD:1312853 6480464 Carbon Tetrachloride results in increased expression of ARHGAP18 mRNA CTD PMID:17484886 thimerosal decreases expression ISO RGD:1312852 6480464 Thimerosal results in decreased expression of ARHGAP18 mRNA CTD PMID:27188386 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of ARHGAP18 mRNA CTD PMID:23411599 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of ARHGAP18 mRNA CTD PMID:34492290 trichloroethene multiple interactions EXP 6480464 [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of ARHGAP18 mRNA CTD PMID:17905399 trichostatin A increases expression ISO RGD:1312852 6480464 trichostatin A results in increased expression of ARHGAP18 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1312852 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP18 mRNA CTD PMID:27188386 triptonide decreases expression ISO RGD:1312853 6480464 triptonide results in decreased expression of ARHGAP18 mRNA CTD PMID:33045310 tungsten decreases expression ISO RGD:1312853 6480464 Tungsten results in decreased expression of ARHGAP18 mRNA CTD PMID:30912803 valproic acid affects expression ISO RGD:1312852 6480464 Valproic Acid affects the expression of ARHGAP18 mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1312852 6480464 Valproic Acid results in increased expression of ARHGAP18 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:1312852 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP18 mRNA CTD PMID:27188386 vancomycin increases expression ISO RGD:1312853 6480464 Vancomycin results in increased expression of ARHGAP18 mRNA CTD PMID:18930951 vincristine decreases expression ISO RGD:1312852 6480464 Vincristine results in decreased expression of ARHGAP18 mRNA CTD PMID:23649840 vorinostat multiple interactions ISO RGD:1312852 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP18 mRNA CTD PMID:27188386 vorinostat increases expression ISO RGD:1312852 6480464 vorinostat results in increased expression of ARHGAP18 mRNA CTD PMID:26272509 , PMID:27188386 zoledronic acid decreases expression ISO RGD:1312852 6480464 zoledronic acid results in decreased expression of ARHGAP18 mRNA CTD PMID:20977926